PP_1170x120_10-25-21

November 21, 2022

You can read the full November 21st print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!

Pressure builds for less costly biologic development

Pressure builds for less costly biologic development

Biologic drugs have increasingly delivered treatments for cancer and rare diseases and continue to prove effective in other wide-ranging areas, from neurological and metabolic disorders to respiratory and cardiovascular diseases. But along with the incredible potential biologics offer, there is also great pressure to discover and deliver novel treatments quickly and cost effectively. Biologics represent

NEXiA frees up pharmacists to focus on patient care

NEXiA frees up pharmacists to focus on patient care

The pandemic increased pharmacists’ already heavy workloads while a simultaneous labor shortage plagued the industry. To help alleviate the burden on pharmacists from laborious and time-consuming prescription filling, iA’s proprietary pharmacy fulfillment software, NEXiA, was developed. NEXiA considerably streamlines processes that rely heavily on manual tasks. Pharmacies’ adoption of technology can free up pharmacists’ time,

The advantages of Synmed’s blister card production

The advantages of Synmed’s blister card production

Automating your pharmacy with SynMed is a way to reduce the workload of your technicians, free up time while reducing errors, and focus on building patient relationships. It is also a way to deliver safe and customized compliance packaging solutions to your patients. Overcome the lack of manpower Overworked, understaffed and less able to connect

Brewer’s strategy producing results at WBA

Brewer’s strategy producing results at WBA

Implementing the strategy mapped out by CEO Roz Brewer, Walgreens Boots Alliance has steadily gained traction over the last 13 months. The latest evidence of the company’s progress came early this month with the announcement that VillageMD, a provider of value-based primary care in which WBA has a majority stake, had agreed to buy Summit

Value-based care an oppportunity for Rx

Value-based care an oppportunity for Rx

In recent years, the health care industry in the U.S. has accelerated its shift from fee-for-service toward value-based care (VBC) models, focused on holistic, long-term outcomes for patients and lower costs for the system. This shift was spearheaded by the Centers for Medicare and Medicaid (CMS) through legislation enacted between 2008 and 2019, notably by

O-T-C hearing aids should be a big draw for seniors

O-T-C hearing aids should be a big draw for seniors

According to our latest research, roughly a quarter of American adults report hearing loss. Still, millions have not invested in a hearing aid or even had their problem diagnosed by a doctor. That begs the question: Why are so many Americans with hearing loss skipping out on hearing aids? The Biden administration thinks accessibility is

Adheris Health